Apolipoprotein ε2 allele is associated with an anti-atherogenic lipoprotein profile in children

The Columbia University biomarkers study

Carmen R. Isasi, Steven Shea, Richard J. Deckelbaum, Sarah C. Couch, Thomas J. Starc, James D. Otvos, Lars Berglund

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Objective. We examined associations between allelic variation in the apo ε gene, which codes for apolipoprotein E, and plasma lipid levels in children. Materials and Methods. We analyzed genotype and fasting lipid levels, including lipid particle size by nuclear magnetic resonance spectroscopy, in 515 children from 297 families. Results. Children carrying the apo ε2 allele (1 or 2 ε2 alleles; n = 45) had higher mean high-density lipoprotein (HDL) cholesterol level (49.5 ± 13.0 vs 42.4 ± 8.9 mg/dL) and lower mean low-density lipoprotein (LDL) cholesterol level (82.2 ± 48.6 vs 105.9 ± 45.0 mg/dL) compared with apo ε3/ε3 children (n = 322). Mean HDL size was larger and mean level of the atheroprotective large HDL subpopulation was higher among apo ε2 carriers compared with ε3/ε3 children (9.5 ± 0.4 vs 9.3 ± .4 nm, and 32.8 ± 9.9 vs 27.6 ± 8.2 mg/dL). In multivariate models adjusting for age, sex, ethnicity, family history, body mass index, and fasting triglyceride level, the apo ε2 allele was independently predictive of higher levels of HDL cholesterol and the large HDL subpopulation and of lower level of LDL cholesterol. Conclusion. The apo ε2 allele is associated with an anti-atherogenic lipid pattern in children.

Original languageEnglish (US)
Pages (from-to)568-575
Number of pages8
JournalPediatrics
Volume106
Issue number3
StatePublished - 2000
Externally publishedYes

Fingerprint

Apolipoproteins
Lipoproteins
Biomarkers
Alleles
HDL Lipoproteins
Lipids
LDL Cholesterol
HDL Cholesterol
Fasting
Apolipoproteins E
Particle Size
Triglycerides
Body Mass Index
Magnetic Resonance Spectroscopy
Genotype
Genes

Keywords

  • Apolipoprotein ε
  • Children
  • Cholesterol

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Isasi, C. R., Shea, S., Deckelbaum, R. J., Couch, S. C., Starc, T. J., Otvos, J. D., & Berglund, L. (2000). Apolipoprotein ε2 allele is associated with an anti-atherogenic lipoprotein profile in children: The Columbia University biomarkers study. Pediatrics, 106(3), 568-575.

Apolipoprotein ε2 allele is associated with an anti-atherogenic lipoprotein profile in children : The Columbia University biomarkers study. / Isasi, Carmen R.; Shea, Steven; Deckelbaum, Richard J.; Couch, Sarah C.; Starc, Thomas J.; Otvos, James D.; Berglund, Lars.

In: Pediatrics, Vol. 106, No. 3, 2000, p. 568-575.

Research output: Contribution to journalArticle

Isasi, CR, Shea, S, Deckelbaum, RJ, Couch, SC, Starc, TJ, Otvos, JD & Berglund, L 2000, 'Apolipoprotein ε2 allele is associated with an anti-atherogenic lipoprotein profile in children: The Columbia University biomarkers study', Pediatrics, vol. 106, no. 3, pp. 568-575.
Isasi, Carmen R. ; Shea, Steven ; Deckelbaum, Richard J. ; Couch, Sarah C. ; Starc, Thomas J. ; Otvos, James D. ; Berglund, Lars. / Apolipoprotein ε2 allele is associated with an anti-atherogenic lipoprotein profile in children : The Columbia University biomarkers study. In: Pediatrics. 2000 ; Vol. 106, No. 3. pp. 568-575.
@article{c8d047b5376c42ddbffb2a3c8a075837,
title = "Apolipoprotein ε2 allele is associated with an anti-atherogenic lipoprotein profile in children: The Columbia University biomarkers study",
abstract = "Objective. We examined associations between allelic variation in the apo ε gene, which codes for apolipoprotein E, and plasma lipid levels in children. Materials and Methods. We analyzed genotype and fasting lipid levels, including lipid particle size by nuclear magnetic resonance spectroscopy, in 515 children from 297 families. Results. Children carrying the apo ε2 allele (1 or 2 ε2 alleles; n = 45) had higher mean high-density lipoprotein (HDL) cholesterol level (49.5 ± 13.0 vs 42.4 ± 8.9 mg/dL) and lower mean low-density lipoprotein (LDL) cholesterol level (82.2 ± 48.6 vs 105.9 ± 45.0 mg/dL) compared with apo ε3/ε3 children (n = 322). Mean HDL size was larger and mean level of the atheroprotective large HDL subpopulation was higher among apo ε2 carriers compared with ε3/ε3 children (9.5 ± 0.4 vs 9.3 ± .4 nm, and 32.8 ± 9.9 vs 27.6 ± 8.2 mg/dL). In multivariate models adjusting for age, sex, ethnicity, family history, body mass index, and fasting triglyceride level, the apo ε2 allele was independently predictive of higher levels of HDL cholesterol and the large HDL subpopulation and of lower level of LDL cholesterol. Conclusion. The apo ε2 allele is associated with an anti-atherogenic lipid pattern in children.",
keywords = "Apolipoprotein ε, Children, Cholesterol",
author = "Isasi, {Carmen R.} and Steven Shea and Deckelbaum, {Richard J.} and Couch, {Sarah C.} and Starc, {Thomas J.} and Otvos, {James D.} and Lars Berglund",
year = "2000",
language = "English (US)",
volume = "106",
pages = "568--575",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "3",

}

TY - JOUR

T1 - Apolipoprotein ε2 allele is associated with an anti-atherogenic lipoprotein profile in children

T2 - The Columbia University biomarkers study

AU - Isasi, Carmen R.

AU - Shea, Steven

AU - Deckelbaum, Richard J.

AU - Couch, Sarah C.

AU - Starc, Thomas J.

AU - Otvos, James D.

AU - Berglund, Lars

PY - 2000

Y1 - 2000

N2 - Objective. We examined associations between allelic variation in the apo ε gene, which codes for apolipoprotein E, and plasma lipid levels in children. Materials and Methods. We analyzed genotype and fasting lipid levels, including lipid particle size by nuclear magnetic resonance spectroscopy, in 515 children from 297 families. Results. Children carrying the apo ε2 allele (1 or 2 ε2 alleles; n = 45) had higher mean high-density lipoprotein (HDL) cholesterol level (49.5 ± 13.0 vs 42.4 ± 8.9 mg/dL) and lower mean low-density lipoprotein (LDL) cholesterol level (82.2 ± 48.6 vs 105.9 ± 45.0 mg/dL) compared with apo ε3/ε3 children (n = 322). Mean HDL size was larger and mean level of the atheroprotective large HDL subpopulation was higher among apo ε2 carriers compared with ε3/ε3 children (9.5 ± 0.4 vs 9.3 ± .4 nm, and 32.8 ± 9.9 vs 27.6 ± 8.2 mg/dL). In multivariate models adjusting for age, sex, ethnicity, family history, body mass index, and fasting triglyceride level, the apo ε2 allele was independently predictive of higher levels of HDL cholesterol and the large HDL subpopulation and of lower level of LDL cholesterol. Conclusion. The apo ε2 allele is associated with an anti-atherogenic lipid pattern in children.

AB - Objective. We examined associations between allelic variation in the apo ε gene, which codes for apolipoprotein E, and plasma lipid levels in children. Materials and Methods. We analyzed genotype and fasting lipid levels, including lipid particle size by nuclear magnetic resonance spectroscopy, in 515 children from 297 families. Results. Children carrying the apo ε2 allele (1 or 2 ε2 alleles; n = 45) had higher mean high-density lipoprotein (HDL) cholesterol level (49.5 ± 13.0 vs 42.4 ± 8.9 mg/dL) and lower mean low-density lipoprotein (LDL) cholesterol level (82.2 ± 48.6 vs 105.9 ± 45.0 mg/dL) compared with apo ε3/ε3 children (n = 322). Mean HDL size was larger and mean level of the atheroprotective large HDL subpopulation was higher among apo ε2 carriers compared with ε3/ε3 children (9.5 ± 0.4 vs 9.3 ± .4 nm, and 32.8 ± 9.9 vs 27.6 ± 8.2 mg/dL). In multivariate models adjusting for age, sex, ethnicity, family history, body mass index, and fasting triglyceride level, the apo ε2 allele was independently predictive of higher levels of HDL cholesterol and the large HDL subpopulation and of lower level of LDL cholesterol. Conclusion. The apo ε2 allele is associated with an anti-atherogenic lipid pattern in children.

KW - Apolipoprotein ε

KW - Children

KW - Cholesterol

UR - http://www.scopus.com/inward/record.url?scp=0033624602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033624602&partnerID=8YFLogxK

M3 - Article

VL - 106

SP - 568

EP - 575

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 3

ER -